- Home
- UNTY vs NNNN Comparison
UNTY vs NNNN Comparison
Compare UNTY & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNTY
- NNNN
- Stock Information
- Founded
- UNTY 1991
- NNNN 2021
- Country
- UNTY United States
- NNNN Germany
- Employees
- UNTY N/A
- NNNN N/A
- Industry
- UNTY Major Banks
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- UNTY Finance
- NNNN Health Care
- Exchange
- UNTY Nasdaq
- NNNN Nasdaq
- Market Cap
- UNTY 432.3M
- NNNN 369.6M
- IPO Year
- UNTY 1997
- NNNN 2025
- Fundamental
- Price
- UNTY $43.79
- NNNN $16.10
- Analyst Decision
- UNTY Buy
- NNNN
- Analyst Count
- UNTY 2
- NNNN 0
- Target Price
- UNTY $52.50
- NNNN N/A
- AVG Volume (30 Days)
- UNTY 60.3K
- NNNN 78.0K
- Earning Date
- UNTY 07-11-2025
- NNNN 01-01-0001
- Dividend Yield
- UNTY 1.28%
- NNNN N/A
- EPS Growth
- UNTY 11.85
- NNNN N/A
- EPS
- UNTY 4.26
- NNNN 0.06
- Revenue
- UNTY $106,250,000.00
- NNNN $8,185,146.00
- Revenue This Year
- UNTY $21.68
- NNNN N/A
- Revenue Next Year
- UNTY $9.98
- NNNN N/A
- P/E Ratio
- UNTY $10.28
- NNNN $286.95
- Revenue Growth
- UNTY 6.60
- NNNN 21.95
- 52 Week Low
- UNTY $25.60
- NNNN $5.18
- 52 Week High
- UNTY $51.22
- NNNN $18.50
- Technical
- Relative Strength Index (RSI)
- UNTY 50.49
- NNNN N/A
- Support Level
- UNTY $43.22
- NNNN N/A
- Resistance Level
- UNTY $44.60
- NNNN N/A
- Average True Range (ATR)
- UNTY 1.23
- NNNN 0.00
- MACD
- UNTY -0.03
- NNNN 0.00
- Stochastic Oscillator
- UNTY 47.86
- NNNN 0.00
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.